Evidence map›Paper›PMID 36986943›Full record

ReviewPlants (Basel, Switzerland)2023

Medicinal Uses of the Fabaceae Family in Zimbabwe: A Review.

Alfred Maroyi

Abstract readReview
In one paragraph

Review in Plants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Ethnomedicinal Uses of Thai Legumes (Food science & nutrition · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Dataset onData in brief · 2026
    Article
  10. Review
  11. Review
  12. Molecules (Basel, Switzerland) · 2025
    Review
  13. Plants (Basel, Switzerland) · 2025
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Comparative Analysis ofMolecules (Basel, Switzerland) · 2025
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Alfred MaroyiDepartment of Botany, University of Fort Hare, Private Bag X1314, Alice 5700, South Africa.ORCID 0000-0001-7965-3415

Funding

University of Fort Hare R188
6 · The paper itself

Abstract

The current study is aimed at providing a systematic review of the ethnomedicinal, phytochemical and pharmacological properties of Fabaceae species used as sources of traditional medicinies in Zimbabwe. Fabaceae is one of the well-known plant families of ethnopharmacological importance. Of the approximately 665 species of the Fabaceae family occurring in Zimbabwe, about 101 are used for medicinal purposes. Many communities in the country, mainly in peri-urban, rural and marginalized areas with limited access to healthcare facilities, rely on traditional medicines as their primary healthcare. The study reviewed research studies undertaken on Zimbabwe's Fabaceae species during 1959 to 2022. Information was gathered from literature sourced from Google Scholar, Science Direct, Scopus, PubMed, books, dissertations, theses and scientific reports. This study showed that 101 species are traditionally used to manage human and animal diseases in Zimbabwe. The genera with the highest number of medicinal uses are

Indexed as

ethnobotanyFabaceaeherbal medicineLeguminosaenatural compoundstraditional knowledgeZimbabwe

Identifiers

PMID36986943
PMCPMC10051751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.